As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abbott Laboratories: Jane Street Group LLC, Parallax Volatility Advisers L.P., Millennium Management LLC, Caption Management LLC, Nomura Holdings Inc., Susquehanna International Group LLP, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Garda Capital Partners LP, Credit Agricole S A, Maven Securities LTD, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., Locust Wood Capital Advisers LLC, Wolverine Asset Management LLC, Citigroup Inc., XY Capital Ltd, Delta Accumulation LLC, Gladius Capital Management LP, Readystate Asset Management LP, Allianz Asset Management GmbH, SteelPeak Wealth LLC, Fulcrum Asset Management LLP, and Wealth Enhancement Advisory Services LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.